Detection of HCV by PCR in serum and PBMC of patients with hepatitis C after treatment

Brazilian Journal of Infectious Diseases

Volumn 11, Issue 5, 2007, Pages 471-474

  Cavalheiro, Norma de Paula ^a,b   Filgueiras, Thelma Cristina ^a   Melo, Carlos Eduardo ^a   Morimitsu, Suzana Rie ^a   de Araújo, Evaldo Stanislau Affonso ^a   Tengan, Fátima Mitiko ^a   Barone, Antonio Alci ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Hepatitis C; PBMC; PCR; Treatment

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION;

EID: 36148958975     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702007000500006     Document Type: Article

References (23)

1. Barth H., Liang T.J., Baumert T.F. Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 2006;44:527-35.
2. Cameron A.M., Busuttil R.W. The status of liver transplantation for hepatitis C. Expert Opin Biol Ther 2006;6:993-1002.
3. Strader D.B., Wright T., Thomas D.I., Seeff L.B. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004;39:1147-71.
4. Simmonds P. Genetic diversity and evolution of hepatitis C. J Gen Virol 2004;85:3173-88.
5. Majda-Stanislawska E., Bednarek M., Jozwiak B., et al. Effect of interferon alfa and ribavirin treatment on hepatitis C virus RNA in serum and peripheral blood mononuclear cells in children with chronic hepatitis C. Acta Gastroenterol Belg 2006;69(2): 187-90.
6. Xu D-Z., Xie Y., Li Z-Q. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C. Hepatobiliary Pancreat Dis Int 2005;4:550-3.
7. Pham T.N.Q., MacParland S.A., Mulrooney P.M., et al. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 2004;78,11:5867-74.
8. Kusaka, S., Okusa T., Araki A., et al. Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells. J Med Virol 1995;46(3):265-8.
9. Mangia CA, Ricci GL., Persico C., et al. A randomized controlled trial of pegylated interferon á-2a (40 KD) or interferon á-2a plus ribavirin and amantadine vs. interferon á-2a and ribavirin in treatment-naïve patients with chronic hepatitis. J. Viral Hep 2005;12:292.
10. Mancuso M.E., Rumi M.G, Santagostino E., et al. High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C. Haematologia 2006; 91:1367-71.
11. Ansaldi F., Torre F., Bruzzone B.M., et al. Evaluation of a new hepatitis C virus sequencing assay as a routine method for genotyping. J Med Virol 2001;63:17-21.
12. Halfon P., Trimoulet P., Bourliere M., et al. Hepatitis C virus genotyping based on 5′ noncoding sequence analysis (Trugene). J Clin Microbiol 2001;39:1771-73.
13. Stuyver L., Wyseur A., Arnhem W., et al. Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol 1996; 34(9):2259-66.
14. Blackard J.T., Smeaton L., Hiasa Y., et al. Detection of hepatitis C virus (HCV) in serum and peripheral-blood mononuclear cells from HCV monoinfected and HIV/HCV coinfected persons. J Infec Dis 2005; 192:258-65.
15. Cavalheiro N.P., Barone A.A, Tengan F.M. HCV Serotypes in Brazilian patients. Int J Infect Dis 2002;6:228-32.
16. Campiotto C., Pinho J.R.R., Carrilho F.J., et al. Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res 2005;38:41-9.
17. Torres M.C,M.R., Pereira L.M.M.B., Ximenes R.A.A., et al, Hepatitis C virus infection in a Brazilian population with sickle-cell anemia. Braz J Med Biol Res 2003;36(3):323-9.
18. Durazzo M., Premoli A, Di'Bisceglie C., et al. Alterations of seminal and hormonal parameters: An extrahepatic manifestation of HCV infection? World J Gastroenterol 2006; 12(19):3073-6.
19. Meier V., Mihm S., Braun PW., Ramadori G. HCV-RNA positivity in peripheral blood mononuclear cells of patients with chronic HCV infection: does it Keality mean viral replication? World J Gastro 2001;7(2):228-34.
20. Trimoulet P., Bernar P.-H., Ledinghen V., et al. Quantitation of hepatitis C virus RNA in plasma and peripheral blood mononuclear cells of patients with chronic hepatitis treated with interferon alfa. Dig Dis Sci 2000;45(1):175-81.
21. Laskus T., Operskalski E.A., Radkowski M., et al. Negative-strand hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCV-positive/HIV-infected women. J Infect Dis 2007; 195(1):124-33.
22. McHutchison J.G., Manns M.P., Longo D.L. Definition and management of anemia in patients with hepatitis C virus. Liver Transp 2006:26:389-98.
23. Hayashi N., Takehara T. Antiviral therapy for hepatitis C: past, present, and future. Review. J Gastro 2006;41:17-27.